[Identification of immunodominant components of an isolate of Trypanosoma cruzi by immunoblot and its standardization for diagnostic purposes].

INTRODUCTION Conventional serology was used for the detection of Trypanosoma cruzi infection, with diverse sensitivity and specificity results. Due to the number of samples with doubtful results, it is necessary to develop additional confirmation tests such as the immunoblot. OBJECTIVE The aim of this study was identify major immunogenic proteins of T. cruzi isolate and establish criteria for immunoblot positivity with diagnostic purposes. METHODS Immunoblot initial standardization was performed, determining optimal concentrations of antigen, serum, and second antibody. Thirty-five positive and thirty negative sera were assayed to evaluate different criteria of positivity and determine which provides greater sensitivity and specificity. RESULTS Immunoblot of T. cruzi positive sera shared a rich pattern of components with molecular weights between 10-250 kDa. Twelve components had a recognition rate higher than 50%, of which the polypeptides of 27, 32, 34, and 38 kDa were close to 100%. Of the positivity criteria evaluated, the recognition of the components of 27 and 32 kDa provided sensitivity and specificity of 100%. DISCUSSION The Immunoblot is suitable for confirmation of infection by T. cruzi, so it is strongly recommended for confirmation and discrimination of discordant cases.

[1]  C. Roodveldt,et al.  Trypanosoma cruzi: identification of a galactose-binding protein that binds to cell surface of human erythrocytes and is involved in cell invasion by the parasite. , 2002, Experimental parasitology.

[2]  C. Barnabé,et al.  Serologic and parasitologic demonstration of Trypanosoma cruzi infections in an urban area of central Mexico: correlation with electrocardiographic alterations. , 2001, The American journal of tropical medicine and hygiene.

[3]  V. Monteón,et al.  Standardization of micro-enzyme-linked immunosorbent assay (ELISA) and Western blot for detection of Trypanosoma cruzi antibodies using extracts from Mexican strains as antigens. , 2001, Archives of medical research.

[4]  De Lima Rivero Ar,et al.  Partial purification and use of Trypanosoma cruzi glycosidic fractions for Chagas disease diagnosis , 2001 .

[5]  A. R. De Lima Rivero,et al.  [Partial purification and use of Trypanosoma cruzi glycosidic fractions for Chagas disease diagnosis]. , 2001, Acta cientifica venezolana.

[6]  E. Segura,et al.  Identification of immunodominant antigens in Mexican strains of Trypanosoma cruzi. , 1999, Immunological investigations.

[7]  H. Okamura,et al.  Evaluation of the western blot in the confirmatory serologic diagnosis of Chagas' disease. , 1998, The American journal of tropical medicine and hygiene.

[8]  J. Borges-Pereira,et al.  Development and evaluation of an enzyme linked immunotransfer blot technique for serodiagnosis of Chagas' disease. , 1994, Tropical medicine and parasitology : official organ of Deutsche Tropenmedizinische Gesellschaft and of Deutsche Gesellschaft fur Technische Zusammenarbeit.

[9]  V. Fernández,et al.  Comparison of chagasic and non-chagasic myocardiopathies by ELISA and immunoblotting with antigens of Trypanosoma cruzi and Trypanosoma rangeli. , 1994, Acta tropica.

[10]  J. Scharfstein,et al.  Trypanosoma cruzi: description of a highly purified surface antigen defined by human antibodies. , 1983, Journal of immunology.

[11]  Z. Cohn,et al.  Trypanosoma cruzi. Surface antigens of blood and culture forms , 1981, The Journal of experimental medicine.

[12]  H. Towbin,et al.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[13]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.